Researchers from the University of Liverpool have outlined a framework for artificial intelligence (AI) to improve antimicrobial use and infection care, helping to address the global challenge of antimicrobial resistance (AMR).
Opioid health risk and medical crisis with a prescription painkiller addiction epidemic concept as a group of people running away from a dangerous falling bridge of pills as a medicine addict problem with 3D illustration elements.
Their blueprint is detailed in a research paper published in The Lancet Digital Health.
Lead author Dr Alex Howard said: “Different forms of AI bring many opportunities to improve healthcare. AIs can harness complex evolving data, inform and augment human actions, and learn from outcomes. The global public health challenge of AMR needs large-scale optimisation of antimicrobial use and wider infection care, which carefully constructed AIs can enable.”
The researchers noted that while AIs become increasingly useful and robust, healthcare systems remain challenging places for their deployment – and an implementation gap exists between the promise of AIs and their use in patient and population care.
With this in mind, the group have outlined an adaptive implementation and maintenance framework for AIs to improve antimicrobial use and infection care as a learning system. This considers AMR problem identification, law/regulation, organisational support and data processing in relation to AMR-targeted AI development, assessment, maintenance, and scalability.
“Bridging the implementation gap between AI innovation and tackling AMR presents technical, regulatory, organisational, and human challenges. Learning systems built on integrated dataflows, governance, and technologies have the potential to close this gap. Translational expertise between AMR and AI fields will be essential to appropriately design, maintain, normalise, and globalise AMR-AIs in infection care and realise the potential for AIs to support clinician-driven AMR minimisation strategies,” Dr Howard said.
The work articulates a vision of how data science can be leveraged to tackle antimicrobial resistance as part of the Centres for Antimicrobial Optimisation Network programme, a global collaborative bringing together world-leading multidisciplinary expertise in infection and health informatics.
Source: University of Liverpool